Nevus, Pigmented  >>  IMM-101  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
IMM-101 / Immodulon
NCT01308762: A Clinical Study, to Evaluate the Safety and Tolerability of Intradermal IMM-101 in Adult Melanoma Cancer Patients

Completed
1
19
Europe
Heat killed whole cell M. obuense (IMM-101) 0.1 mg, IMM-101, Mycobaterium obuense, Heat-killed whole cell M.obuense (IMM-101) 0.5 mg, Heat killed whole cell M.obuense (IMM-101) 1.0 mg
Immodulon Therapeutics Ltd, HCA International Limited, Theradex
Melanoma
09/10
09/10

Download Options